Skip to main content
SpringerLink
Log in
Book cover

Pediatric CNS Tumors pp 313–334Cite as

Advances in Radiation Therapy

  • Chapter

  • 1700 Accesses

Part of the book series: Pediatric Oncology ((PEDIATRICO))

Despite the known effects of ionizing radiation on the nervous system, most children with brain tumors have to undergo radiation therapy at some point during their treatment. As advances in neurosurgery, chemotherapy, and radiotherapy enter clinical practice, multimodality therapy has become the norm. For any tumor, the incorporation of radiation therapy into such treatment must consider the timing, dose, and treatment volume of radiation, the most appropriate radiation modality, short- and long-term toxicities, both for radiation alone and for radiation in conjunction with chemotherapy, and, finally, the integration of novel antineoplastic agents with radiation.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   239.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Anteunis LJ, Wanders SL, Hendriks JJ, Langendijk JA, Manni JJ, de Jong JM (1994) A prospective longitudinal study on radiation-induced hearing loss. American Journal of Surgery 168:408–411

    PubMed  CAS  Google Scholar 

  • Barani IJ, Cuttino LW, Benedict SH, Todor D, Bump EA, Wu Y, Chung TD, Broaddus WC, Lin PS (2007) Neural stem cell-preserving external-beam radiotherapy of central nervous system malignancies. International Journal of Radiation Oncology, Biology, Physics 68:978–985

    PubMed  Google Scholar 

  • Barker FG 2nd, Simmons ML, Chang SM, Prados MD, Larson DA, Sneed PK, Wara WM, Berger MS, Chen P, Israel MA, Aldape KD (2001) EGFR overexpression and radiation response in glioblastoma multiforme. International Journal of Radiation Oncology, Biology, Physics 51:410–418

    PubMed  CAS  Google Scholar 

  • Batchelor TT, Sorensen AG, di Tomaso E, Zhang WT, Duda DG, Cohen KS, Kozak KR, Cahill DP, Chen PJ, Zhu M, Ancuk-iewicz M, Mrugala MM, Plotkin S, Drappatz J, Louis DN, Ivy P, Scadden DT, Benner T, Loeffler JS, Wen PY, Jain RK (2007) AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients. Cancer Cell 11:83–95

    PubMed  CAS  Google Scholar 

  • Battermann JJ (1980) Fast neutron therapy for advanced tumors. International Journal of Radiation Oncology, Biology, Physics 6:333–335

    PubMed  CAS  Google Scholar 

  • Baumann M, Krause M, Dikomey E, Dittmann K, Dorr W, Kasten-Pisula U, Rodemann HP (2007) EGFR-targeted anti-cancer drugs in radiotherapy: preclinical evaluation of mechanisms. Radiotherapy & Oncology 83:238–248

    CAS  Google Scholar 

  • Boldrey E, Sheline G (1966) Delayed transitory clinical manifestations after radiation treatment of intracranial tumors. Acta Radiologica: Therapy, Physics, Biology 5:5–10

    CAS  Google Scholar 

  • Bourne HR, Sanders DA, McCormick F (1990) The GTPase superfamily: a conserved switch for diverse cell functions. Nature 348:125–132

    PubMed  CAS  Google Scholar 

  • Bowers DC, Liu Y, Leisenring W, McNeil E, Stovall M, Gur-ney JG, Robison LL, Packer RJ, Oeffinger KC (2006) Late-occurring stroke among long-term survivors of childhood leukemia and brain tumors: a report from the Childhood Cancer Survivor Study. Journal of Clinical Oncology 24:5277–5282

    PubMed  Google Scholar 

  • Brown JM (1999) The hypoxic cell: a target for selective cancer therapy—eighteenth Bruce F. Cain Memorial Award lecture. Cancer Research 59:5863–5870

    PubMed  CAS  Google Scholar 

  • Brown JM, Giaccia AJ (1994) Tumour hypoxia: the picture has changed in the 1990s. International Journal of Radiation Biology 65:95–102

    PubMed  CAS  Google Scholar 

  • Carmeliet P, Jain RK (2000) Angiogenesis in cancer and other diseases. Nature 407:249–257

    PubMed  CAS  Google Scholar 

  • Catteral M, Bloom HJG, Ash DV, Walsh L, Richardson A, Utt-ley D, Gowing NFC, Lewis P, Chaucer B (1980) Fast neutrons compared with megavoltage x-rays in the treatment of patients with supratentorial glioblastoma: a controlled pilot study. International Journal of Radiation Oncology, Biology, Physics 6:261–266

    Google Scholar 

  • Chadha M, Capala J, Coderre JA, Elowitz EH, Iwai J-I, Joel DD, Liu HB, Wielopolski L, Chanana AD (1998) Boron neutron-capture therapy (BNCT) for glioblastoma multi-forme (GBM) using the epithermal neutron beam at the Brookhaven National Laboratory. International Journal of Radiation Oncology, Biology, Physics 40:829–834

    PubMed  CAS  Google Scholar 

  • Cloughesy TF, Wen PY, Robins HI, Chang SM, Groves MD, Fink KL, Junck L, Schiff D, Abrey L, Gilbert MR, Lieberman F, Kuhn J, DeAngelis LM, Mehta M, Raizer JJ, Yung WK, Aldape K, Wright J, Lamborn KR, Prados MD (2006) Phase II trial of tipifarnib in patients with recurrent malignant glioma either receiving or not receiving enzyme-inducing antiepi-leptic drugs: a North American Brain Tumor Consortium Study. Journal of Clinical Oncology 24:3651–3656

    PubMed  CAS  Google Scholar 

  • Combs SE, Heeger S, Haselmann R, Edler L, Debus J, Schulz-Ertner D (2006) Treatment of primary glioblastoma mul-tiforme with cetuximab, radiotherapy and temozolomide (GERT). phase I/II trial: study protocol. BMC Cancer 6:133

    PubMed  Google Scholar 

  • Copeland DR, Fletcher JM, Pfefferbaum-Levine B, Jaffe N, Ried H, Maor M (1985) Neuropsychological sequelae of childhood cancer in long-term survivors. Pediatrics 75:745–753

    PubMed  CAS  Google Scholar 

  • Demetri GD (2001) Targeting c-kit mutations in solid tumors: scientific rationale and novel therapeutic options. Seminars in Oncology 28:19–26

    PubMed  CAS  Google Scholar 

  • Desjardins A, Quinn JA, Vredenburgh JJ, Sathornsumetee S, Friedman AH, Herndon JE, McLendon RE, Provenzale JM, Rich JN, Sampson JH, Gururangan S, Dowell JM, Salvado A, Friedman HS, Reardon DA (2007) Phase II study of imatinib mesylate and hydroxyurea for recurrent grade III malignant gliomas. Journal of Neurooncology 83:53–60

    CAS  Google Scholar 

  • Diaz AZ, Coderre JA, Chanana AD, Ma R (2000) Boron neutron capture therapy for malignant gliomas. Annals of Medicine 32:81–85

    PubMed  CAS  Google Scholar 

  • Dings RP, Loren M, Heun H, McNiel E, Griffioen AW, Mayo KH, Griffin RJ (2007) Scheduling of radiation with angio-genesis inhibitors anginex and Avastin improves therapeutic outcome via vessel normalization. Clinical Cancer Research 13:3395–3402

    PubMed  CAS  Google Scholar 

  • Donahue B (1992) Short- and long-term complications of radiation therapy for pediatric brain tumors. Pediatric Neuro-surgery 18:207–217

    CAS  Google Scholar 

  • Downward J (1996) Control of ras activation. Cancer Surveys 27:87–100

    PubMed  CAS  Google Scholar 

  • Drebin JA, Link VC, Stern DF, Weinberg RA, Greene MI (1985) Down-modulation of an oncogene protein product and reversion of the transformed phenotype by monoclonal antibodies. Cell 41:697–706

    PubMed  CAS  Google Scholar 

  • Drebin JA, Link VC, Weinberg RA, Greene MI (1986) Inhibition of tumor growth by a monoclonal antibody reactive with an oncogene-encoded tumor antigen. Proceedings of the National Academy of Sciences of the United States of America 83:9129–9133

    PubMed  CAS  Google Scholar 

  • Du W, Lebowitz PF, Prendergast GC (1999) Cell growth inhibition by farnesyltransferase inhibitors is mediated by gain of geranylgeranylated RhoB. Molecular and Cellular Biology 19:1831–1840

    PubMed  CAS  Google Scholar 

  • Ekstrand AJ, James CD, Cavenee WK, Seliger B, Pettersson RF, Collins VP (1991) Genes for epidermal growth factor receptor, transforming growth factor alpha, and epidermal growth factor and their expression in human gliomas in vivo. Cancer Research 51:2164–2172

    PubMed  CAS  Google Scholar 

  • Ekstrand AJ, Sugawa N, James CD, Collins VP (1992) Amplified and rearranged epidermal growth factor receptor genes in human glioblastomas reveal deletions of sequences encoding portions of the N- and/or C-terminal tails. Proceedings of the National Academy of Sciences of the United States of America 89:4309–4313

    PubMed  CAS  Google Scholar 

  • Emami B, Lyman J, Brown A, Coia L, Goitein M, Munzenrider JE, Shank B, Solin LJ, Wesson M (1991) Tolerance of normal tissue to therapeutic irradiation. International Journal of Radiation Oncology, Biology, Physics 21:109–122

    PubMed  CAS  Google Scholar 

  • Fan Z, Mendelsohn J (1998) Therapeutic application of anti-growth factor receptor antibodies. Current Opinion in Oncology 10:67–73

    PubMed  CAS  Google Scholar 

  • Fan QW, Weiss WA (2006) Isoform specific inhibitors of PI3 kinase in glioma. Cell Cycle 5:2301–2305

    PubMed  CAS  Google Scholar 

  • Fine HA (2007) Promising new therapies for malignant gliomas. Cancer Journal 13:349–354

    CAS  Google Scholar 

  • Fong TA, Shawver LK, Sun L, Tang C, App H, Powell TJ, Kim YH, Schreck R, Wang X, Risau W, Ullrich A, Hirth K P, McMahon G (1999) SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types. Cancer Research 59:99–106

    PubMed  CAS  Google Scholar 

  • Fouladi M, Nicholson HS, Zhou T, Laningham F, Helton KJ, Holmes E, Cohen K, Speights RA, Wright J, Pollack IF (2007) A phase II study of the farnesyl transferase inhibitor, tipifarnib, in children with recurrent or progressive high-grade glioma, medulloblastoma/primitive neuroec-todermal tumor, or brainstem glioma: a Children's Oncology Group study. Cancer 110:2535–2541

    PubMed  CAS  Google Scholar 

  • Fry DW, Kraker AJ, McMichael A, Ambroso LA, Nelson JM, Leopold WR, Connors RW, Bridges AJ (1994) A specific inhibitor of the epidermal growth factor receptor tyrosine kinase. Science 265:1093–1095

    PubMed  CAS  Google Scholar 

  • Galanis E, Buckner JC, Maurer MJ, Kreisberg JI, Ballman K, Boni J, Peralba JM, Jenkins RB, Dakhil SR, Morton RF, Jaeckle KA, Scheithauer BW, Dancey J, Hidalgo M, Walsh DJ (2005) Phase II trial of temsirolimus (CCI-779) in recurrent glio-blastoma multiforme: a North Central Cancer Treatment Group Study. Journal of Clinical Oncology 23:5294–5304

    PubMed  CAS  Google Scholar 

  • Goldstein NI, Prewett M, Zuklys K, Rockwell P, Mendelsohn J (1995) Biological efficacy of a chimeric antibody to the epidermal growth factor receptor in a human tumor xeno-graft model. Clinical Cancer Research 1:1311–1318

    PubMed  CAS  Google Scholar 

  • Gorski DH, Beckett MA, Jaskowiak NT, Calvin D P, Mauceri HJ, Salloum RM, Seetharam S, Koons A, Hari DM, Kufe DW, Weichselbaum RR (1999) Blockage of the vascular endothe-lial growth factor stress response increases the antitumor effects of ionizing radiation. Cancer Research 59:3374–3378

    PubMed  CAS  Google Scholar 

  • Grau C, Overgaard J (1996) Postirradiation sensorineural hearing loss: a common but ignored late radiation complication. International Journal of Radiation Oncology, Biology, Physics 36:515–517

    PubMed  CAS  Google Scholar 

  • Grau C, Moller K, Overgaard M, Overgaard J, Elbrond O (1991) Sensori-neural hearing loss in patients treated with irradiation for nasopharyngeal carcinoma. International Journal of Radiation Oncology, Biology, Physics 21:723–728

    PubMed  CAS  Google Scholar 

  • Griffin TW, Davis R, Laramore G (1983) Fast neutron radiation therapy for glioblastoma multiforme–results of an RTOG study. American Journal of Clinical Oncology 6:661–667

    PubMed  CAS  Google Scholar 

  • Gutierrez AN, Westerly DC, Tome WA, Jaradat HA, Mackie TR, Bentzen SM, Khuntia D, Mehta MP (2007) Whole brain radiotherapy with hippocampal avoidance and simultaneously integrated brain metastases boost: a planning study. International Journal of Radiation Oncology, Biology, Physics 69:589–597

    PubMed  Google Scholar 

  • Halberg FE, Kramer JH, Moore IM, Wara WM, Matthay KK, Ablin AR (1992) Prophylactic cranial irradiation dose effects on late cognitive function in children treated for acute lymphoblastic leukemia. International Journal of Radiation Oncology, Biology, Physics 22:13–16

    PubMed  CAS  Google Scholar 

  • Hall EJ (2000) Radiobiology for the radiologist. Lippincott Williams & Wilkins, Philadelphia

    Google Scholar 

  • Hall EJ (2006) Intensity-modulated radiation therapy, protons, and the risk of second cancers. International Journal of Radiation Oncology, Biology, Physics 65:1–7

    PubMed  Google Scholar 

  • Halperin EC, Burger PC (1985) Conventional external beam radiotherapy for central nervous system malignancies. Neurologic Clinics 3:867–882

    PubMed  CAS  Google Scholar 

  • Hermanson M, Funa K, Hartman M, Claesson-Welsh L, Heldin CH, Westermark B, Nister M (1992) Platelet-derived growth factor and its receptors in human glioma tissue: expression of messenger RNA and protein suggests the presence of auto-crine and paracrine loops. Cancer Research 52:3213–3219

    PubMed  CAS  Google Scholar 

  • Hermanson M, Funa K, Koopmann J, Maintz D, Waha A, West-ermark B, Heldin CH, Wiestler OD, Louis DN, von Deimling A, Nister M (1996) Association of loss of heterozygosity on chromosome 17p with high platelet-derived growth factor alpha receptor expression in human malignant gliomas. Cancer Research 56:164–171

    PubMed  CAS  Google Scholar 

  • Hermanto U, Frija EK, Lii MJ, Chang EL, Mahajan A, Woo SY (2007) Intensity-modulated radiotherapy (IMRT) and conventional three-dimensional conformal radiotherapy for high-grade gliomas: does IMRT increase the integral dose to normal brain? International Journal of Radiation Oncology, Biology, Physics 67:1135–1144

    PubMed  Google Scholar 

  • Hodgson DC, Goumnerova LC, Loeffler JS, Dutton S, Black PM, Alexander E 3rd, Xu R, Kooy H, Silver B, Tarbell NJ (2001) Radiosurgery in the management of pediatric brain tumors. International Journal of Radiation Oncology, Biology, Physics 50:929–935

    PubMed  CAS  Google Scholar 

  • Huang SM, Bock JM, Harari PM (1999) Epidermal growth factor receptor blockade with C225 modulates proliferation, apoptosis, and radiosensitivity in squamous cell carcinomas of the head and neck. Cancer Research 59:1935–1940

    PubMed  CAS  Google Scholar 

  • Huang E, Teh BS, Strother DR, Davis QG, Chiu JK, Lu HH, Carpenter LS, Mai WY, Chintagumpala MM, South M, Grant WH 3rd, Butler EB, Woo SY (2002) Intensity-modulated radiation therapy for pediatric medulloblastoma: early report on the reduction of ototoxicity. International Journal of Radiation Oncology, Biology, Physics 52:599–605

    PubMed  Google Scholar 

  • Hunter T (2000) Signaling–2000 and beyond. Cell 100:113–127

    PubMed  CAS  Google Scholar 

  • Jones HA, Hahn SM, Bernhard E, McKenna WG (2001) Ras inhibitors and radiation therapy. Seminars in Radiation Oncology 11:328–337

    PubMed  CAS  Google Scholar 

  • Kalapurakal JA, Thomas PR (1997) Pediatric radiotherapy. An overview. Radiologic Clinics of North America 35:1265– 1280

    CAS  Google Scholar 

  • Kalapurakal JA, Goldman S, Stellpflug W, Curran J, Sathiasee-lan V, Marymont MH, Tomita T (2006) Phase I study of intraoperative radiotherapy with photon radiosurgery system in children with recurrent brain tumors: preliminary report of first dose level (10 Gy). International Journal of Radiation Oncology, Biology, Physics 65:800–808

    PubMed  Google Scholar 

  • Klapper LN, Kirschbaum MH, Sela M, Yarden Y (2000) Biochemical and clinical implications of the ErbB/HER signaling network of growth factor receptors. Advances in Cancer Research 77:25–79

    PubMed  CAS  Google Scholar 

  • Klohs WD, Fry DW, Kraker AJ (1997) Inhibitors of tyrosine kinase. Current Opinion in Oncology 9:562–568

    PubMed  CAS  Google Scholar 

  • Kondziolka D, Flickinger JC, Lunsford LD (2000) Stereotac-tic radiosurgery and radiation therapy. In: Bernstein M, Berger MS (eds) Neuro-oncology: the essentials. Thieme, New York, pp 183–197

    Google Scholar 

  • Kramer S, Lee KF (1974) Complications of radiation therapy: the central nervous system. Seminars in Roentgenology 9:75–83

    PubMed  CAS  Google Scholar 

  • Lai A, Filka E, McGibbon B, Nghiemphu PL, Graham C, Yong WH, Mischel P, Liau LM, Bergsneider M, Pope W, Selch M, Cloughesy T (2008) Phase II pilot study of bevacizumab in combination with temozolomide and regional radiation therapy for up-front treatment of patients with newly diagnosed glioblastoma multiforme: interim analysis of safety and tolerability. International Journal of Radiation Oncology, Biology, Physics 71:1372–1380

    PubMed  CAS  Google Scholar 

  • Laird AD, Vajkoczy P, Shawver LK, Thurnher A, Liang C, Mohammadi M, Schlessinger J, Ullrich A, Hubbard SR, Blake RA, Fong TA, Strawn LM, Sun L, Tang C, Hawtin R, Tang F, Shenoy N, Hirth K P, McMahon G, Cherrington (2000) SU6668 is a potent antiangiogenic and antitumor agent that induces regression of established tumors. Cancer Research 60:4152–4160

    PubMed  CAS  Google Scholar 

  • Lampert H, Alegria A (1964) Treatment of post-poliomyelitis paralysis of long duration. Acta Neurológica Latinoameri-cana 10:160–171

    CAS  Google Scholar 

  • Lang FF, Yung WK, Sawaya R, Tofilon PJ (1999) Adenovirus-mediated p53 gene therapy for human gliomas. Neurosur-gery 45:1093–1104

    CAS  Google Scholar 

  • Laramore GE, Diener-West M, Griffin TW, Nelson JS, Griem ML, Thomas FJ, Hendrickson FR, Griffin BR, Myriantho-poulos LC, Saxton J (1988) Randomized neutron dose searching study for malignant gliomas of the brain: results of an RTOG study. International Journal of Radiation Oncology, Biology, Physics 14:1093–1102

    PubMed  CAS  Google Scholar 

  • Lasota J, Jasinski M, Sarlomo-Rikala M, Miettinen M (1999) Mutations in exon 11 of c-Kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas. American Journal of Pathology 154:53–60

    PubMed  CAS  Google Scholar 

  • Lebowitz PF, Prendergast GC (1998) Non-Ras targets of farne-syltransferase inhibitors: focus on Rho. Oncogene 17:1439– 1445

    PubMed  CAS  Google Scholar 

  • Levitzki A, Gazit A (1995) Tyrosine kinase inhibition: an approach to drug development. Science 267:1782–1788

    PubMed  CAS  Google Scholar 

  • Littman P, Rosenstock J, Gale G, Krisch RE, Meadows A, Sather H, Coccia P, DeCamargo B (1984) The somnolence syndrome in leukemic children following reduced daily dose fractions of cranial radiation. International Journal of Radiation Oncology, Biology, Physics 10:1851–1853

    PubMed  CAS  Google Scholar 

  • Loeffler JS, Siddon RL, Wen PY, Nedzi LA, Alexander E 3rd (1990) Stereotactic radiosurgery of the brain using a standard linear accelerator: a study of early and late effects. Radiotherapy & Oncology 17:311–321

    CAS  Google Scholar 

  • Lowy DR, Willumsen BM (1993) Function and regulation of ras. Annual Review of Biochemistry 62:851–891

    PubMed  CAS  Google Scholar 

  • MacDonald SM, Safai S, Trofimov A, Wolfgang J, Fullerton B, Yeap BY, Bortfeld T, Tarbell NJ, Yock T (2008) Proton radiotherapy for childhood ependymoma: initial clinical outcomes and dose comparisons. International Journal of Radiation Oncology, Biology, Physics 71:979–986

    PubMed  Google Scholar 

  • Marcus KJ, Goumnerova L, Billett AL, Lavally B, Scott RM, Bishop K, Xu R, Young Poussaint T, Kieran M, Kooy H, Pomeroy SL, Tarbell NJ (2005) Stereotactic radiotherapy for localized low-grade gliomas in children: final results of a prospective trial. International Journal of Radiation Oncology, Biology, Physics 61:374–379

    PubMed  Google Scholar 

  • Maxwell M, Naber SP, Wolfe HJ, Galanopoulos T, Hedley-Whyte ET, Black PM, Antoniades HN (1990) Coexpression of platelet-derived growth factor (PDGF) and PDGF-receptor genes by primary human astrocytomas may contribute to their development and maintenance. Journal of Clinical Investigations 86:131–140

    CAS  Google Scholar 

  • Mellinghoff IK, Wang MY, Vivanco I, Haas-Kogan DA, Zhu S, Dia EQ, Lu K V, Yoshimoto K, Huang JH, Chute DJ, Riggs BL, Horvath S, Liau LM, Cavenee WK, Rao PN, Beroukhim R, Peck TC, Lee JC, Sellers WR, Stokoe D, Prados M, Cloughesy TF, Sawyers CL, Mischel PS (2005) Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors. New England Journal of Medicine 353:2012–2024

    PubMed  CAS  Google Scholar 

  • Mendelsohn J, Baselga J (2000) The EGF receptor family as targets for cancer therapy. Oncogene 19:6550–6565

    PubMed  CAS  Google Scholar 

  • Merchant TE, Goloubeva O, Pritchard DL, Gaber MW, Xiong X, Danish RK, Lustig RH (2002) Radiation dose-volume effects on growth hormone secretion. International Journal of Radiation Oncology, Biology, Physics 52:1264–1270

    PubMed  CAS  Google Scholar 

  • Merchant TE, Hua CH, Shukla H, Ying X, Nill S, Oelfke U (2008) Proton versus photon radiotherapy for common pediatric brain tumors: comparison of models of dose characteristics and their relationship to cognitive function. Pediatric Blood & Cancer 51:110–117

    Google Scholar 

  • Milas L, Mason K, Hunter N, Petersen S, Yamakawa M, Ang K, Mendelsohn J, Fan Z (2000) In vivo enhancement of tumor radioresponse by C225 antiepidermal growth factor receptor antibody. Clinical Cancer Research 6:701–708

    PubMed  CAS  Google Scholar 

  • Miyaguchi M, Takeuchi T, Morimoto K, Kubo T (1998) Correlation of epidermal growth factor receptor and radio-sensitivity in human maxillary carcinoma cell lines. Acta Oto-Laryngologica 118:428–431

    PubMed  CAS  Google Scholar 

  • Mulhern RK, Ochs J, Fairclough D (1992) Deterioration of intellect among children surviving leukemia: IQ test changes modify estimates of treatment toxicity. Journal of Consulting and Clinical Psychology 60:477–480

    PubMed  CAS  Google Scholar 

  • Neglia JP, Robison LL, Stovall M, Liu Y, Packer RJ, Hammond S, Yasui Y, Kasper CE, Mertens AC, Donaldson SS, Meadows AT, Inskip PD (2006) New primary neoplasms of the central nervous system in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Journal of National Cancer Institute 98:1528–1537

    Google Scholar 

  • Nozaki M, Tada M, Kobayashi H, Zhang CL, Sawamura Y, Abe H, Ishii N, Van Meir EG (1999) Roles of the functional loss of p53 and other genes in astrocytoma tumorigenesis and progression. Neuro-oncology 1:124–137

    PubMed  CAS  Google Scholar 

  • Nyugen TD, Lassman AB, Lis E, Rosen N, Shaffer DR, Scher HI, DeAngelis LM, Abrey LE (2006) A pilot study to assess the tolerability and efficacy of RAD-001 (everolimus) with gefitinib in patients with recurrent glioblastoma multi-forme (GBM). Journal of Clinical Oncology, 2006 ASCO Annual Meeting Proceedings Part I 24:1507

    Google Scholar 

  • Olayioye MA, Neve RM, Lane HA, Hynes NE (2000) The ErbB signaling network: receptor heterodimerization in development and cancer. EMBO J 19:3159–3167

    PubMed  CAS  Google Scholar 

  • Pawson T, Scott JD (1997) Signaling through scaffold, anchoring, and adaptor proteins. Science 278:2075–2080

    PubMed  CAS  Google Scholar 

  • Pillai MR, Jayaprakash PG, Nair MK (1998) Tumour-proliferative fraction and growth factor expression as markers of tumour response to radiotherapy in cancer of the uterine cervix. Journal of Cancer Research and Clinical Oncology 124:456–461

    PubMed  CAS  Google Scholar 

  • Porter AC, Vaillancourt RR (1998) Tyrosine kinase receptor-activated signal transduction pathways which lead to oncogenesis. Oncogene 17:1343–1352

    PubMed  CAS  Google Scholar 

  • Presta LG, Chen H, O'Connor SJ, Chisholm V, Meng YG, Krum-men L, Winkler M, Ferrara N (1997) Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders. Cancer Research 57:4593–4599

    PubMed  CAS  Google Scholar 

  • Purdy JA (1999) 3D treatment planning and intensity-modulated radiation therapy. Oncology 13:155–168

    PubMed  CAS  Google Scholar 

  • Reardon DA, Egorin MJ, Quinn JA, Rich JN, Gururangan S, Vre-denburgh JJ, Desjardins A, Sathornsumetee S, Provenzale JM, Herndon JE II, Dowell JM, Badruddoja MA, McLendon RE, Lagattuta TF, Kicielinski KP, Dresemann G, Sampson JH, Friedman AH, Salvado AJ, Friedman HS (2005) Phase II study of imatinib mesylate plus hydroxyurea in adults with recurrent glioblastoma multiforme. Journal of Clinical Oncology 23:9359–9368

    PubMed  CAS  Google Scholar 

  • Reuter CW, Morgan MA, Bergmann L (2000) Targeting the Ras signaling pathway: a rational, mechanism-based treatment for hematologic malignancies? Blood 96:1655–1669

    PubMed  CAS  Google Scholar 

  • Rostomily RC, Halligan J, Geyer R, Stelzer K, Lindsley K, Berger MS (2001) Permanent low-activity (125)I seed placement for the treatment of pediatric brain tumors: preliminary experience. Pediatric Neurosurgery 34:198–205

    PubMed  CAS  Google Scholar 

  • Rowinsky EK, Windle JJ, Von Hoff DD (1999) Ras protein farne-syltransferase: A strategic target for anticancer therapeutic development. Journal of Clinical Oncology 17:3631–3652

    PubMed  CAS  Google Scholar 

  • Rowland JH, Glidewell OJ, Sibley RF, Holland JC, Tull R, Ber-man A, Brecher ML, Harris M, Glicksman AS, Forman E et al (1984) Effects of different forms of central nervous system prophylaxis on neuropsychologic function in childhood leukemia. Journal of Clinical Oncology 2:1327–1335

    PubMed  CAS  Google Scholar 

  • Sawyers CL (2002) Rational therapeutic intervention in cancer: kinases as drug targets. Current Opinion in Genetics and Development 12:111–115

    PubMed  CAS  Google Scholar 

  • Schell MJ, McHaney VA, Green AA, Kun LE, Hayes FA, Horowitz M, Meyer WH (1989) Hearing loss in children and young adults receiving cisplatin with or without prior cranial irradiation. Journal of Clinical Oncology 7:754–760

    PubMed  CAS  Google Scholar 

  • Sheridan MT, O'Dwyer T, Seymour CB, Mothersill CE (1997) Potential indicators of radiosensitivity in squamous cell carcinoma of the head and neck. Radiation Oncology Investigations 5:180–186

    PubMed  CAS  Google Scholar 

  • Sneed PK, Russo C, Scharfen CO, Prados MD, Malec MK, Larson DA, Lamborn KR, Lamb SA, Voss B, Weaver KA, Phillips TL, Gutin PH, Wara WM, Edwards MS (1996) Long-term follow-up after high-activity 125I brachytherapy for pediatric brain tumors. Pediatric Neurosurgery 24:314–322

    PubMed  CAS  Google Scholar 

  • St Clair WH, Adams JA, Bues M, Fullerton BC, La Shell S, Kooy HM, Loeffler JS, Tarbell NJ (2004) Advantage of protons compared to conventional X-ray or IMRT in the treatment of a pediatric patient with medulloblastoma. International Journal of Radiation Oncology, Biology, Physics 58:727–734

    CAS  Google Scholar 

  • Suit H (2002) The Gray Lecture 2001: coming technical advances in radiation oncology. International Journal of Radiation Oncology, Biology, Physics 53:798–809

    PubMed  Google Scholar 

  • Syndikus I, Tait D, Ashley S, Jannoun L (1994) Long-term follow-up of young children with brain tumors after irradiation. International Journal of Radiation Oncology, Biology, Physics 30:781–787

    PubMed  CAS  Google Scholar 

  • Taniguchi M, Nishida T, Hirota S, Isozaki K, Ito T, Nomura T, Matsuda H, Kitamura Y (1999) Effect of c-kit mutation on prognosis of gastrointestinal stromal tumors. Cancer Research 59:4297–4300

    PubMed  CAS  Google Scholar 

  • Verhey LJ (1999) Comparison of three-dimensional conformal radiation therapy and intensity-modulated radiation therapy systems. Seminars in Radiation Oncology 9:78–98

    PubMed  CAS  Google Scholar 

  • von Deimling A, Louis DN, von Ammon K, Petersen I, Hoell T, Chung RY, Martuza RL, Schoenfeld DA, Yasargil MG, Wies-tler OD et al (1992) Association of epidermal growth factor receptor gene amplification with loss of chromosome 10 in human glioblastoma multiforme. Journal of Neurosurgery 77:295–301

    Google Scholar 

  • Vredenburgh JJ, Desjardins A, Herndon JE 2nd, Marcello J, Reardon DA, Quinn JA, Rich JN, Sathornsumetee S, Guru-rangan S, Sampson J, Wagner M, Bailey L, Bigner DD, Friedman AH, Friedman HS (2007) Bevacizumab plus irinotecan in recurrent glioblastoma multiforme. Journal of Clinical Oncology 25:4722–4729

    PubMed  CAS  Google Scholar 

  • Waber D P, Tarbell NJ, Kahn CM, Gelber RD, Sallan SE (1992) The relationship of sex and treatment modality to neurop-sychologic outcome in childhood acute lymphoblastic leukemia. Journal of Clinical Oncology 10:810–817

    PubMed  CAS  Google Scholar 

  • Walker DA, Pillow J, Waters KD, Keir E (1989) Enhanced cis-platinum ototoxicity in children with brain tumours who have received simultaneous or prior cranial irradiation. Medical and Pediatric Oncology 17:48–52

    PubMed  CAS  Google Scholar 

  • Wara WM, Phillips TL, Sheline GE, Schwade JG (1975) Radiation tolerance of the spinal cord. Cancer 35:1558–1562

    PubMed  CAS  Google Scholar 

  • Webb S (2000) Advances in three-dimensional conformal radiation therapy physics with intensity modulation. Lancet Oncology 1:30–36

    PubMed  CAS  Google Scholar 

  • Weil MD (2001) Conformal radiotherapy for brain tumors. Hematology/oncology Clinics of North America 15:1007– 1015

    PubMed  CAS  Google Scholar 

  • Wen PY, Yung WK, Lamborn KR, Dahia PL, Wang Y, Peng B, Abrey LE, Raizer J, Cloughesy TF, Fink K, Gilbert M, Chang S, Junck L, Schiff D, Lieberman F, Fine HA, Mehta M, Robins HI, DeAngelis LM, Groves MD, Puduvalli VK, Levin V, Conrad C, Maher EA, Aldape K, Hayes M, Letvak L, Egorin MJ, Capdeville R, Kaplan R, Murgo AJ, Stiles C, Prados MD (2006) Phase I/II study of imatinib mesy-late for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99–08. Clinical Cancer Research 12:4899–4907

    PubMed  CAS  Google Scholar 

  • Westermark B, Heldin CH, Nistér M (1995) Platelet-derived growth factor in human glioma. Glia 15:257–263

    PubMed  CAS  Google Scholar 

  • Wikstrand CJ, McLendon RE, Friedman AH, Bigner DD (1997) Cell surface localization and density of the tumor-associated variant of the epidermal growth factor receptor, EGFRvIII. Cancer Research 57:4130–4140

    PubMed  CAS  Google Scholar 

  • Willett CG (2001) Intraoperative radiation therapy. International Journal of Clinical Oncology 6:209–214

    PubMed  CAS  Google Scholar 

  • Wollman R, Yahalom J, Maxy R, Pinto J, Fuks Z (1994) Effect of epidermal growth factor on the growth and radiation sensitivity of human breast cancer cells in vitro. International Journal of Radiation Oncology, Biology, Physics 30:91–98

    PubMed  CAS  Google Scholar 

  • Wong AJ, Bigner SH, Bigner DD, Kinzler KW, Hamilton SR, Vogelstein B (1987) Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. Proceedings of the National Academy of Sciences of the United States of America 84:6899–6903

    PubMed  CAS  Google Scholar 

  • Yang TC (1999) Proton radiobiology and uncertainties. Radiation Measures 30:383–392

    CAS  Google Scholar 

  • Yang W, Wu G, Barth RF, Swindall MR, Bandyopadhyaya AK, Tjarks W, Tordoff K, Moeschberger M, Sferra TJ, Binns PJ, Riley KJ, Ciesielski MJ, Fenstermaker RA, Wikstrand CJ (2008) Molecular targeting and treatment of composite EGFR and EGFRvIII-positive gliomas using boronated monoclonal antibodies. Clinical Cancer Research 14:883–891

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology Harvard Radiation Oncology Program, Massachusetts General Hospital, 100 Blossom Street, Boston, MA, 02215, USA

    Sean M. McBride

  2. Departments of Radiation Oncology and Neurological Surgery Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, 1600 Divisadero Street, San Francisco, CA, 94115-1708, USA

    Daphne A. Haas-Kogan

Authors
  1. Sean M. McBride
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Daphne A. Haas-Kogan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sean M. McBride .

Editor information

Editors and Affiliations

  1. Departments of Neurological Surgery and Pediatrics, Division of Pediatric Neurosurgery, University of California San Francisco, 505 Parnassus Avenue, Rm M779, San Francisco, CA, 94143-0112, USA

    Nalin Gupta

  2. Departments of Pediatrics and Neurological Surgery, Division of Hematology and Oncology, University of California San Francisco, 505 Parnassus Avenue, San Francisco, CA, 94143-0106, USA

    Anuradha Banerjee

  3. Departments of Radiation Oncology and Neurological Surgery, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, 1600 Divisadero Street, San Francisco, CA, 94115-1708, USA

    Daphne Haas-Kogan

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

McBride, S.M., Haas-Kogan, D.A. (2010). Advances in Radiation Therapy. In: Gupta, N., Banerjee, A., Haas-Kogan, D. (eds) Pediatric CNS Tumors. Pediatric Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-87979-4_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-87979-4_16

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-87976-3

  • Online ISBN: 978-3-540-87979-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation